Background: Exercise has been reported to decrease cancer-related fatigue and to increase quality of life (QoL) in various breast cancer (BC) populations. However, studies investigating exercise during radiotherapy or resistance training are scarce. We conducted a randomized, controlled trial (BEST study) to assess the efficacy of 12-week resistance training on fatigue beyond possible psychosocial effects of a group-based intervention.
introduction
Many breast cancer (BC) patients receive radiotherapy and are thus confronted with cancer-related fatigue as the most frequent side-effect, with severe impact on quality of life (QoL) [1] . Despite increasing evidence that exercise may be an effective treatment of fatigue, exercise during radiotherapy has rarely been investigated [2] . To our knowledge, only one small randomized exercise trial (N = 46) specifically investigated BC patients during radiotherapy [3] . Four other exercise trials reported on mixed patient populations, including BC patients during adjuvant radiotherapy [4] [5] [6] [7] .
Further clarification is also needed on which types of exercise are beneficial. Benefits of both aerobic and resistance training on fatigue and QoL have been reported [2, 8, 9 ]. Yet, the majority of randomized exercise trials investigated pure aerobic or combined aerobic and resistance training. Thus, the effects of muscle strengthening exercise are still understudied [10] .
In addition, it is still unclear whether exercise interventions reduce fatigue and improve QoL primarily through psychosocial effects. It has been shown that group-based, supervised exercise produces positive psychosocial 'side-effects' due to social interactions, improved self-efficacy, and attention from a trainer [11] , which potentially contribute to lower fatigue and higher QoL. As most previous studies compared exercise interventions to usual care, physiological effects beyond psychosocial grouprelated effects could not be studied. Thus, the BEST study aimed to evaluate the efficacy of resistance training beyond the psychosocial benefits associated with a group-based nonexercise intervention on fatigue and QoL in 160 BC patients receiving adjuvant radiotherapy.
methods study design
The BEST study is a prospective, randomized, controlled intervention trial evaluating a 12-week resistance training in stage 0-III BC patients during adjuvant radiotherapy. To determine the effect of exercise per se, the control group received a supervised group-based muscle-relaxation program. Both interventions began parallel to the first radiotherapy. End points were assessed before start of radiotherapy (baseline, T0), postradiotherapy (week 7, T1), and postintervention (week 13, T2). The study was approved by the ethics committee of the University of Heidelberg and registered at ClinicalTrials.gov (NCT01468766). Details of the study design are described elsewhere [12] .
patients Eligibility criteria were: histologically confirmed primary BC; stage 0-III after lumpectomy or mastectomy; scheduled for radiotherapy; age ≥18 years; body mass index (BMI) ≥18 kg/m 2 ; ability to understand and follow the study protocol; and willingness to come to the exercise facilities. Patients with contraindications for resistance training (e.g. acute infectious disease, severe cardiac disease, severe respiratory insufficiency), patients with other concomitant malignant diseases (except carcinoma in situ of skin or cervix), and patients who were currently participating in systematic intense exercise training (at least 1 h twice/week) or who had previously participated in an exercise intervention trial were excluded on screening. All participants gave written informed consent.
recruitment and randomization
Eligible patients scheduled for adjuvant radiotherapy at the University of Heidelberg Medical Center between February 2011 and March 2013 were contacted in clinic. Interested patients were informed in detail by the BEST study physicians and study coordinators. Patients who signed the written informed consent underwent, within 21 days before the start of radiation, a baseline assessment at the National Center for Tumor Diseases (NCT), including a check for contraindications. Eligible participants were randomly allocated to 1 : 1 to the exercise (EX) group or relaxation control (RC) group. Allocation was done by a biometrician who was not involved in the recruitment procedure, based on predetermined lists with a random block size, stratified by age and baseline physical fatigue level. Study personnel did not have access to the randomization lists.
interventions Both interventions were administered for about 60 min twice weekly over a 12-week period together with other cancer patients under the supervision of trained and experienced physiotherapists in specific training facilities at the study center. The intervention started at the day of the first radiotherapy treatment. Physical status, adverse events and adherence were recorded for each training session by the participants and the trainers. The progressive exercise intervention comprised eight different machine-based resistance exercises (3 sets, 8-12 repetitions at 60%-80% of 1 repitition maximum) [12] . The control group carried out progressive muscle relaxation without any aerobic or muscle strengthening components.
outcome measures
The primary end point was change of cancer-related fatigue from baseline to week 13. Fatigue was assessed with the Fatigue Assessment Questionnaire (FAQ), a 20-item, self-assessment questionnaire validated for a Germanspeaking population [13] . It covers the physical, affective and cognitive fatigue dimensions. Scores are on a 0-100 scale, with higher scores indicating worse fatigue.
QoL was assessed with the validated, 30-item self-assessment questionnaire of the European Organisation for Research and Treatment of Cancer (EORTC QLQ-C30, version 3.0) [14] . In addition, the 23-item BC-specific EORTC QLQ-BR23 was applied.
Depressive symptoms were self-assessed with the 20-item CES-D scale, a validated instrument for cancer patients [15] . Cognitive function was estimated with the trail-making test, a reliable and valid measure used in neuropsychological diagnostics [16] .
Muscle strength was measured for isometric and isokinetic muscle capacity of representative muscle groups for upper and lower extremity [12] . Endurance performance (VO 2 peak) was measured on a bicycle ergometer. The procedure was also used to identify exercise-contraindicating cardiac impairments.
safety
Potential adverse effects (e.g. lymphedema, pain, muscle soreness, nausea, dyspnea, tachycardia) were recorded by the participants at each training session, using standardized questionnaires. Adverse events reported spontaneously by the patient or observed by therapists were also recorded.
sample size and statistical analysis
The study was designed to detect a standardized effect size (ES) of 0.5 for total fatigue with a two-sided t-test of power of 80% at 5% significance level. Thus, 64 patients per arm were needed for analysis. Assuming a maximal dropout rate of 20%, 80 patients were recruited per arm.
Data were analyzed on the intent-to-treat (ITT) basis. Analysis of covariance (ANCOVA) was used with pre-to postintervention change as dependent variable, the intervention group as independent variable, and the baseline measure as covariate. To fulfill the normality assumption, fatigue parameters were square-root transformed. Transformation of EORTC parameters was not needed. As the number of missing fatigue values was very low (3%), we carried out complete-case analyses. Confounding and effect modification by potential influencing factors, such as age, baseline BMI, and treatment characteristics, were investigated. Further sensitivity analyses were carried out, using ordinal logistic regression, to investigate robustness of results for the EORTC symptoms that are based only on single items. Results did not differ substantially from the ANCOVA results. We made no adjustment for multiple comparisons for the secondary outcomes, which were considered to be explorative analyses. Standardized ESs were calculated for all outcomes by dividing the between-group difference of the postintervention means (adjusted for baseline values) by the pooled baseline standard deviation. For ease of presentation, ES in favor of EX received a positive sign and in favor of RC a negative sign. All statistical tests were two-sided, and P < 0.05 was considered statistically significant. SAS Version 9.3 was used for all analyses.
results
A total of 321 BC patients were personally informed about the study, 170 gave written informed consent and underwent baseline diagnostics, of which 160 patients were randomized for the BEST study, 80 to EX and 80 to RC (Figure 1) . Pre-and postintervention assessment of the primary end point was available in a total of 155 (97%) participants, 77 in EX and 78 in RC. Demographics and treatment characteristics did not differ significantly between both intervention groups (Table 1) . Mean age was 56 years (range 29-75 years). The majority of patients had not received any chemotherapy before radiotherapy (64%). Neoadjuvant chemotherapy had been completed by 19% of the patients [median time to baseline: 9 weeks, 1st to 3rd quartile range (QR): 8-11 weeks]. The other patients (16%) had completed adjuvant chemotherapy shortly before baseline (median: 3.5 weeks, QR: 2.7-5.0 weeks). All primary and secondary outcome variables were equally distributed in EX and RC at baseline (all P > 0.05), except for the EORTC symptom dry mouth (P = 0.033).
Adherence was similar in both groups. Of 24 scheduled sessions, the median attended number was 19 (QR: 13-23, range 1-24) in EX and 19 (QR: 12-22, range 0-24) in RC. In EX, significant improvements were observed for muscle strength, e.g. in isokinetic knee flexion (P < 0.0001), but not for cardiorespiratory fitness. No injuries or severe adverse events related to the interventions were reported. The frequency of reported lymphedema did not differ between groups.
primary end point
Overall, from pre-to postintervention, total cancer-related fatigue decreased significantly in EX, while in RC there was no significant change (Table 2) . Correspondingly, the primary ITT analysis showed significant differences between both intervention groups (P = 0.044) with ES = 0.25 (supplementary Figure S1 , available at Annals of Oncology online). Considering the different fatigue dimensions, the effect was significant regarding physical fatigue (P = 0.013, ES = 0.33), but not for the affective (P = 0.91, ES = 0.01) or the cognitive (P = 0.65, ES = 0.07) dimension.
secondary end points
Investigation of the EORTC QoL scores (Table 3 , supplementary Figure S1 , available at Annals of Oncology online) revealed a significant increase in global QoL in EX from pre-to postintervention but no significant change in RC, but the between-group difference was small and nonsignificant (P = 0.37, ES = 0.15). Significantly larger improvements in EX versus RC were detected in role function (P = 0.035, ES = 0.31) and in pain (P = 0.040, ES = 0.25). Future perspective improved significantly more in RC compared with EX (P = 0.047, ES = 0.28).
Emotional function, social function, and body image improved significantly in both intervention groups, without a significant between-group difference. Further, small effects in favor of EX were observed for several QoL symptoms. However, these effects failed to reach statistical significance (Table 3) . Regarding the CES-D depression score, there was no significant change from pre-to postintervention in either of the intervention groups (Table 3 , supplementary Figure S1 , available at Annals of Oncology online). Overall cognitive performance improved slightly more in EX than in RC, but between-group differences were nonsignificant.
The results remained stable when adjusting the ANCOVA models for randomization strata or other potential influencing factors, such as age, previous chemotherapy, baseline BMI, baseline depression, sports in the year before diagnosis, or living status (alone/with others). No significant interactions were observed.
discussion
We report here the results of a large randomized, controlled trial in BC patients testing the effects of exercise during adjuvant radiotherapy. The 12-week resistance exercise program was an efficacious strategy to reduce the primary end point total fatigue, particularly physical fatigue. Furthermore, improvements in some subscales of QoL were observed. The program was safe and had good adherence. Since group-based relaxation training was chosen as the control group, our results indicate that resistance exercise provides beneficial effects beyond psychosocial effects induced by group-based programs.
Several studies have investigated the effect of exercise on fatigue in BC patients. A meta-analysis including 25 randomized exercise intervention trials reported an overall ES of 0.39 [95% confidence interval (CI) 0.27-0.51] [2] . Our study adds to current knowledge for BC patients with respect to two understudied areas: (i) exercise was carried out during radiotherapy; and (ii) the type of training was pure resistance exercise. So far, only three randomized studies analyzed resistance exercise interventions without aerobic components with respect to fatigue or QoL [8, 17, 18] . One study [17] randomly assigned 242 patients receiving chemotherapy to resistance exercise, aerobic exercise, or usual care, but did not observe significant effects, possibly due to the high variability of outcomes during chemotherapy. Another study [18] also reported no difference in fatigue among 106 postmenopausal survivors randomized to a 1-year resistance exercise or stretching program. Yet results were limited by a nonrandom dropout rate of 37%. The third study [8] did not investigate fatigue, but observed significant improvements in the physical and the psychosocial QoL score among 86 survivors randomized to resistance training compared with usual care.
We chose a group-based control intervention with psychosocial conditions similar to the exercise program and for which beneficial effects on fatigue were shown [19] . Thus, our observed effects for resistance training likely refer to physiological effects of exercise, over and above the psychosocial benefits associated with group-based programs. The clinically relevant overall effect of resistance exercise compared with usual care can therefore be expected to be higher than the one observed in our study.
For general QoL, our observed ES of 0.15 was smaller than the ES of 0.34 (95% CI 0.07-0.62) reported by a meta-analysis on randomized exercise studies in BC patients during adjuvant therapy [20] , presumably due to choosing an active control group in our study with psychosocial benefits too. Our analyses regarding QoL functions and symptoms suggest that resistance training also has physiological effects on QoL. Compared with RC, there were improvements in role function and pain. The benefit regarding pain is especially relevant, because patients and physicians are often concerned that intense resistance exercise may increase side-effects. On the other hand, patients in the relaxation group were less concerned about the future, reflecting rather psychological aspects. Although we did not correct for multiple testing so that some findings might have appeared by chance, our results strengthen observations from a Cochrane review that exercise has beneficial effects on QoL [21] . It is not surprising that no differences in emotional and social functions between EX and RC were found, because psychosocial interventions, including relaxation programs, may also have beneficial effects on emotional distress [11] . Accordingly, while previous randomized intervention trials reported reduced depression in exercise programs compared with usual care [22] , we did not observe benefits of EX over RC regarding depression.
In conclusion, our large randomized, controlled intervention trial indicates that resistance exercise is safe, feasible as well as efficacious in improving cancer-related fatigue and components of QoL in BC patients during adjuvant radiotherapy. With fatigue being the most frequent side-effect during radiotherapy, this finding is clinically meaningful to many BC patients. The observed physiological effects of resistance exercise are over and above psychosocial benefits associated with group-based supervised programs. Our results substantiate the claim that resistance training should become an integral part of exercise prescriptions for BC patients and that these programs should begin parallel to adjuvant radiotherapy.
